tiprankstipranks
Trending News
More News >
Genpact (G)
NYSE:G

Genpact (G) AI Stock Analysis

Compare
918 Followers

Top Page

G

Genpact

(NYSE:G)

Select Model
Select Model
Select Model
Outperform 73 (OpenAI - 5.2)
Rating:73Outperform
Price Target:
$45.00
▲(19.87% Upside)
Action:ReiteratedDate:02/07/26
The score is driven primarily by strong financial fundamentals (improving leverage, solid profitability and free cash flow) and a constructive earnings outlook with margin and EPS expansion guidance. These strengths are tempered by weak technicals (below key moving averages with negative MACD) despite oversold conditions, while a low P/E and moderate dividend yield provide additional support.
Positive Factors
Strengthened balance sheet / lower leverage
Material reduction in leverage to ~0.23x materially lowers financial risk and increases strategic optionality. A conservative capital structure supports investment in ATS and AI, sustains capital returns, and improves resilience to cyclical slowdowns over the next several quarters.
Consistent, high-quality cash generation
Sustained free cash flow conversion (mid-80s to low-90s percent of net income) underpins durable shareholder returns and reinvestment. Reliable cash generation funds buybacks/dividends, technology investment and deal execution without reliance on new financing over a 2–6 month horizon.
AI/ATS product and go-to-market momentum
Rapid scaling of GenAI solutions, a growing data/AI pipeline and partner-led revenue indicate a structural shift to higher-value, scalable offerings. This should support higher growth and margin mix durability as ATS and AI-driven services become a larger, recurring part of revenue.
Negative Factors
Net-margin step-down
A persistent ~300bp decline in net margin reduces the company's ability to convert operating gains into bottom-line profits. If pressures below the operating line persist, earnings leverage from revenue growth and ATS expansion may be muted over coming quarters.
Large-deal timing and sales-cycle variability
Heavy dependence on large, complex deals adds structural timing and execution risk; delayed conversions can cause lumpy revenue and margin recognition. Over a 2–6 month horizon, this variability can disrupt expected growth pacing and cash flow consistency.
One-time client prepayment supporting cash flow
A $170M client prepayment materially boosted 2025 operating cash flow, masking underlying organic cash conversion. Reliance on timing-sensitive receipts introduces volatility in reported cash flow and limits visibility into sustainable free cash generation.

Genpact (G) vs. SPDR S&P 500 ETF (SPY)

Genpact Business Overview & Revenue Model

Company DescriptionGenpact Limited provides business process outsourcing and information technology (IT) services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Banking, Capital Markets and Insurance; Consumer Goods, Retail, Life Sciences and Healthcare; and High Tech, Manufacturing and Services. The company offers CFO advisory services; and environmental, social, and governance (ESG) services, such as data management, carbon accounting, human rights assessment, sustainability diligence, and ESG reporting. It also provides finance and accounting services, which include accounts payable, such as document management, invoice processing, approval and resolution management, and travel and expense processing; invoice-to-cash services, including customer master data management, credit and contract management, fulfillment, billing, collections, and dispute management services; record to report services comprising accounting, treasury, tax, product cost accounting, and closing and reporting services; financial planning and analysis consisting of budgeting, forecasting, and business performance reporting; and enterprise risk and compliance services, including operational risks and controls. In addition, the company provides supply chain advisory services, and after-sales services; sourcing and procurement services comprising direct and indirect strategic sourcing, category management, spend analytics, procurement operation, and master data management; and sales and commercial services, including campaign, order, and dispute management, lead generation, pricing, and promotion optimization. Further, it offers IT services, which comprise end-user computing support, infrastructure management, application production support, and database management services; and transformation services that include digital solutions, consulting services, and analytics services and solutions. The company was founded in 1997 and is based in Hamilton, Bermuda.
How the Company Makes MoneyGenpact generates revenue through a diversified model that includes multiple streams. Primarily, the company earns money by providing consulting and outsourcing services to clients, which encompasses business process outsourcing (BPO), IT services, and application management. Another significant revenue stream arises from technology solutions that integrate advanced analytics, automation, and digital tools into client operations. Furthermore, Genpact has established strategic partnerships with leading technology providers, enabling it to enhance its service offerings and expand its market reach. These collaborations, along with a strong focus on innovation and client-specific solutions, contribute to the company's overall earnings and growth in the competitive landscape.

Genpact Key Performance Indicators (KPIs)

Any
Any
Number of Clients Greater Than $25m Revenue
Number of Clients Greater Than $25m Revenue
Indicates the number of major clients contributing significantly to revenue, highlighting reliance on large accounts and potential risks if any major client is lost.
Chart InsightsGenpact has consistently increased its number of high-revenue clients, reaching 46 by early 2025, reflecting strong client acquisition and retention strategies. The recent earnings call highlights a strategic shift towards Data-Tech-AI, which is driving revenue growth despite macroeconomic challenges. However, delays in large deals, particularly in manufacturing and consumer goods, pose risks to future growth. The company's robust pipeline and focus on innovative solutions suggest potential for continued expansion, although cautious guidance reflects current uncertainties.
Data provided by:The Fly

Genpact Earnings Call Summary

Earnings Call Date:Feb 05, 2026
(Q4-2025)
|
% Change Since: |
Next Earnings Date:May 13, 2026
Earnings Call Sentiment Positive
The call conveyed strong, broad-based progress: record revenue, significant acceleration in Advanced Technology Solutions (ATS), meaningful margin expansion, robust bookings and backlog, accelerating agentic (AgenTeq) traction, expanding product pipeline and partner momentum, and disciplined capital returns. Weaknesses were limited: softness in decision support services, modest consumer & healthcare growth, some reliance on a client prepayment for cash-flow benefit, variable large-deal timing, ongoing client productivity demands, and a higher effective tax rate. Overall, positives (growth, margin expansion, bookings, product/AI momentum) materially outweigh the listed challenges, and management provided constructive 2026 guidance.
Q4-2025 Updates
Positive Updates
Record Annual Revenue
Full-year 2025 revenue of $5.08 billion, up 6.6% year over year, marking a record year for Genpact.
Rapid Advanced Technology Solutions (ATS) Growth
ATS revenue grew 17% in 2025 to approximately $1.20 billion (24% of total revenue), contributing more than half of total revenue growth and expected to grow at least in the high teens in 2026.
Strong Q4 ATS & Segment Performance
Q4 ATS revenue increased 15% to $323 million; data, tech & AI revenue rose 7.4% in Q4 to $639 million (9.3% growth for the full year to $2.442 billion); digital operations increased 4% in Q4 to $681 million.
Agentic Solutions Traction
AgenTeq closed over $200 million TCV in 2025 with >40% of awarded contract value from new clients; AP Suite adoption examples (e.g., Vesco) show meaningful operational improvements and accelerated uptake.
Operational & Margin Expansion
Gross margin expanded 60 basis points in 2025 to 36.0% (Q4 gross margin ~36.6%, +90 bps YoY); adjusted operating income margin improved 40 basis points to 17.5% for the year (Q4 AOI margin 17.6%).
EPS and Profitability Gains
Adjusted diluted EPS reached a record $3.65 for 2025, up 11.3% year over year; Q4 adjusted diluted EPS of $0.97, up 6.6% and growing faster than revenue for the fifth consecutive year; full-year net income was $552 million.
Robust Bookings, Backlog and Large Deals
Over $5.5 billion in new bookings in 2025, 16 large deals closed during the year, and management reports a record-high backlog entering 2026 with more large-deal awards than at the start of any prior fiscal year.
Cash, Capital Return and Liquidity
Cash and cash equivalents ended Q4 at $854 million (up $207 million YoY); operating cash flow of $813 million for 2025 (includes $170 million client prepayment); returned $401 million to shareholders in 2025 via $283 million buybacks and $118 million dividends.
Product & Go-to-Market Momentum
AI Gigafactory scaled to >400 GenAI solutions in market (nearly 3x YoY); data & AI pipeline up 50% YoY; partner-related revenue grew nearly 50% YoY; company now >7,000 AI builders and nearly 20,000 AI practitioners.
Clear 2026 Financial Guidance
Management guides 2026 revenue growth of at least 7% (as-reported), ATS growth at least in the high teens, further gross margin expansion of ~50 bps to 36.5%, adjusted operating income margin up ~25 bps to 17.7%, and adjusted diluted EPS growth ~10%.
Negative Updates
Softness in Decision Support Services
Core business services growth was partially offset by softness in decision support services in Q4, weighing on overall core segment momentum.
Slower End-Market Growth in Consumer & Healthcare
Consumer and healthcare revenue grew only 1.5% for the year, lagging other verticals such as high-tech & manufacturing (+9.9%) and financial services (+5%).
Reliance on a Client Prepayment for Cash Flow Boost
Operating cash flow of $813 million in 2025 includes $170 million from a client prepayment in Q3/Q4; excluding that item, cash flow from operations rose a more modest 5% YoY, indicating some one-time support to reported cash flow.
Sales Cycle and Large-Deal Timing Variability
Management noted that large and complex deals can have variable and sometimes lengthy sales cycles and ramps, creating timing uncertainty for conversion even as pipeline is strong.
Ongoing Productivity & Pricing Pressure
Clients maintain high productivity and efficiency expectations (pricing pressure), requiring continued delivery of productivity gains; management highlighted this remains an ongoing dynamic even though they are currently offsetting impacts.
Higher Effective Tax Rate
Effective tax rate increased to 24.2% in Q4 and 24.3% for the full year (the prior-year rate benefited from a nonrecurring discrete item), representing a headwind to after-tax results.
Inconsistent Dividend/Disclosure Language in Transcript
Transcript contains conflicting language around the dividend increase (references to a 10% increase to $18.75 per quarter and 75¢ on an annual basis), creating ambiguity about the precise dividend amount communicated to investors.
Company Guidance
Genpact guided to at least 7% revenue growth for fiscal 2026 (as‑reported) with Advanced Technology Solutions accelerating to at least high‑teens growth, full‑year gross margin expanding ~50 basis points to 36.5% and adjusted operating income margin up ~25 basis points to 17.7%, driving ~10% growth in adjusted diluted EPS (outpacing revenue); management reiterated a balanced capital allocation approach targeting roughly 50% of operating cash flow returned to shareholders via buybacks/dividends and announced a 10% increase in the regular quarterly dividend, noted committed revenue near historical levels (~75%) and a record backlog, and provided Q1 targets of $1.282–$1.294 billion revenue (≈6% growth at midpoint), ATS accelerating to high‑teens, Q1 gross margin 36.3%, Q1 adjusted operating income margin 17.3% and adjusted diluted EPS of $0.92–$0.93.

Genpact Financial Statement Overview

Summary
Strong multi-year revenue growth with healthy operating margins and consistently positive free cash flow. Balance sheet is a standout with materially improved leverage and solid ROE. Offsets include a step-down in net margin after 2023 and some volatility in operating cash flow conversion.
Income Statement
78
Positive
Revenue has grown steadily from 2020 to 2025 (about $3.7B to $5.1B), with the latest year showing a strong acceleration in growth. Profitability is healthy and fairly consistent, with gross margins in the mid-30% range and operating margins in the mid-teens. A key weakness is that net margin peaked in 2023 (~14%) and then stepped down to ~11% in 2024–2025, signaling some pressure below the operating line even as scale improves.
Balance Sheet
83
Very Positive
Leverage has improved meaningfully, with debt-to-equity falling from above 1.0x in 2020–2021 to ~0.23x in 2025, indicating a much more conservative capital structure. Equity has grown over time, and returns on equity remain strong (roughly low-20% range in 2024–2025, higher in 2023). The main watch item is that total assets have risen alongside growth, so maintaining these returns will depend on continued margin discipline and efficient deployment of the asset base.
Cash Flow
75
Positive
Cash generation is solid: free cash flow is consistently high relative to net income (roughly mid-80% to low-90% across years), supporting quality of earnings. Free cash flow has expanded strongly in 2024–2025 versus prior years, rebounding from a dip in 2022. The key weakness is variability in cash conversion year-to-year (operating cash flow coverage fluctuates), which suggests working-capital timing or other operating cash flow swings that investors should monitor.
BreakdownDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue5.08B4.77B4.48B4.37B4.02B
Gross Profit1.81B1.69B1.57B1.54B1.43B
EBITDA874.70M852.58M772.52M652.86M709.01M
Net Income552.49M513.67M631.25M353.40M369.45M
Balance Sheet
Total Assets5.84B4.99B4.81B4.59B4.98B
Cash, Cash Equivalents and Short-Term Investments1.20B671.61M583.67M646.76M899.46M
Total Debt1.90B1.45B1.50B1.70B2.00B
Total Liabilities3.29B2.60B2.56B2.76B3.08B
Stockholders Equity2.55B2.39B2.25B1.83B1.90B
Cash Flow
Free Cash Flow734.65M530.19M432.04M389.28M637.03M
Operating Cash Flow812.86M615.42M490.81M443.67M694.28M
Investing Cash Flow-495.50M-105.96M-78.94M-36.59M-122.75M
Financing Cash Flow-106.81M-424.85M-483.00M-571.40M-332.88M

Genpact Technical Analysis

Technical Analysis Sentiment
Negative
Last Price37.54
Price Trends
50DMA
44.38
Negative
100DMA
43.06
Negative
200DMA
43.22
Negative
Market Momentum
MACD
-1.91
Negative
RSI
35.25
Neutral
STOCH
61.46
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For G, the sentiment is Negative. The current price of 37.54 is below the 20-day moving average (MA) of 40.27, below the 50-day MA of 44.38, and below the 200-day MA of 43.22, indicating a bearish trend. The MACD of -1.91 indicates Negative momentum. The RSI at 35.25 is Neutral, neither overbought nor oversold. The STOCH value of 61.46 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for G.

Genpact Risk Analysis

Genpact disclosed 43 risk factors in its most recent earnings report. Genpact reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Genpact Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$6.76B12.5222.37%1.41%7.40%-14.45%
72
Outperform
$4.90B20.6025.96%14.43%29.86%
68
Neutral
$9.26B20.6710.34%14.26%-15.49%
62
Neutral
$2.30B5.7413.79%-4.13%2143.48%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
53
Neutral
$2.96B12.1921.77%-1.90%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
G
Genpact
37.54
-14.08
-27.28%
EPAM
Epam Systems
129.96
-80.54
-38.26%
EXLS
Exlservice Holdings
28.51
-20.19
-41.46%
DXC
DXC Technology
11.85
-6.70
-36.12%
KD
Kyndryl Holdings Incorporation
11.41
-25.63
-69.20%

Genpact Corporate Events

Business Operations and StrategyPrivate Placements and Financing
Genpact Completes $350 Million Senior Notes Offering
Neutral
Nov 18, 2025

On November 18, 2025, Genpact UK Finco plc and Genpact USA, Inc., subsidiaries of Genpact Limited, completed a $350 million public offering of 4.950% Senior Notes due 2030. The notes are guaranteed by Genpact and Genpact Luxembourg and are intended to be used for general corporate purposes, including potentially repaying existing notes due in 2026. This move is part of Genpact’s strategic financial management to optimize its debt structure and support its ongoing operations.

The most recent analyst rating on (G) stock is a Hold with a $51.00 price target. To see the full list of analyst forecasts on Genpact stock, see the G Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Feb 07, 2026